<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/74C9BE1A-DF07-4388-B5F3-BEE269771544"><gtr:id>74C9BE1A-DF07-4388-B5F3-BEE269771544</gtr:id><gtr:name>Royal Institution of Great Britain</gtr:name><gtr:address><gtr:line1>The Royal Institution</gtr:line1><gtr:line2>21 Albemarle Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>W1S 4BS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/74C9BE1A-DF07-4388-B5F3-BEE269771544"><gtr:id>74C9BE1A-DF07-4388-B5F3-BEE269771544</gtr:id><gtr:name>Royal Institution of Great Britain</gtr:name><gtr:address><gtr:line1>The Royal Institution</gtr:line1><gtr:line2>21 Albemarle Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>W1S 4BS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/31D6FF73-C4C8-4FE1-93A2-E00FA28722DC"><gtr:id>31D6FF73-C4C8-4FE1-93A2-E00FA28722DC</gtr:id><gtr:firstName>Sam</gtr:firstName><gtr:surname>Janes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F596"><gtr:id>1C69721F-A9FE-4C02-AE3C-53C9B0440491</gtr:id><gtr:title>Identifying lung airway stem cells and understanding their cell fate decisions in the development of lung cancer.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/596</gtr:grantReference><gtr:abstractText>Lung cancer is the leading cause of cancer death in the world. Cancers, such as breast, prostate and colorectal, have seen new principles and innovations in diagnostic testing and treatment strategies improve survival rates dramatically. These improvements have in part been due to improved diagnosis and treatment of pre-cancerous lesions, where the cancer has not fully developed or spread and remains treatable. As a research group based in the Rayne Institute Centre for Respiratory Research, University College London, we hope to identify cells involved in the generation of lung cancers and determine the factors within the cells that commonly lead to their development. It now appears that a normal cells behaviour can be converted into that of a cancer cell by the same messages, but uncontrolled, that govern the development of the lungs in the womb. We intend to investigate one particular candidate pathway termed the Wnt pathway, involved in lung development, that we believe is also involved in the development of early lung cancer lesions. Our investigations hope to identify the cells responsible for cancer development and the messages responsible for their abnormal behaviour, particularly in early cancer lesions and that this may lead to new therapeutic possibilities.</gtr:abstractText><gtr:technicalSummary>Lung cancer is the leading cause of death due to neoplasia in the world. Cancers, such as breast, prostate and colorectal, have seen new principles and innovations in diagnostic testing and treatment strategies improve survival rates dramatically. These improvements have been partly due to improved diagnosis and treatment of pre-invasive lesions. Stem cell longevity within airways allows for the accumulation of the multiple genetic hits required for cancer formation. However the identification of these stem cells and markers for them has proved problematic. Identifying stem cells and their inappropriately regulated intrinsic and extrinsic molecular cues is vital in understanding lung cancer development and will direct future therapeutic strategies in targeting treatments to pre-invasive lesions. 
Low retinoic acid receptor RAR ) expression is related to the development of squamous metaplasia. RA activity on RAR responsive promotors is potentiated by -catenin, a key signalling molecule in the Wnt pathway, while retinoids decrease signalling through the -catenin/TCF/LEF pathway by RARs competing with TCF/Lef for -catenin binding. Hence the reduction of RAR expression in lung epithelium may cause metaplastic differentiation through upregulation of -catenin/Tcf/Lef complex signalling.
The aim of my proposal is threefold.
1 To fully characterise normal lung airway stem cells.
2 To determine the effects of -catenin signalling on decisions of stem cell fate.
3 To examine -catenin expression in the human metaplasia - dysplasia - carcinoma-in-situ model of squamous carcinoma of the lung. 
First I will use lineage marking experiments to investigate the full stem cell potential of keratin 14 positive cells in the upper trachea. Subsequently by expressing constitutively active -catenin or c-Myc (promoting -catenin signalling), or a dominant negative Lef1 (inhibiting -catenin signalling) in these putative stem cells, I will determine the effects of the transgene expression on cell behaviour. Finally I will investigate whether the -catenin signalling system is involved in the abnormal program of differentiation seen in the human metaplasia - dysplasia - carcinoma-in-situ model of squamous carcinoma of the lung. The identification of developmentally regulated pathways that are also active in cancer formation will provide important clues into the early developmental process of pre-invasive cancer formation and may direct future treatments in the prevention of lung cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2008-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>692995</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johnson &amp; Johnson</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cell therapy for lung fibrosis</gtr:description><gtr:id>EA9DBF1D-C0E1-43E2-AB4B-D942F9AB3C28</gtr:id><gtr:impact>JnJ funded a post doctoral worker for a project shortly after I received my Clinician Scientist Fellowship, largely because of the MRC award. Two Aguilar et al publications were produced.PMID: 19956603; PMID: 17363552</gtr:impact><gtr:outcomeId>FF92C46A963-1</gtr:outcomeId><gtr:partnerContribution>JnJ funded a post doctoral worker for a project shortly after I received my Clinician Scientist Fellowship, largely because of the MRC award.</gtr:partnerContribution><gtr:piContribution>I supervised a post doctoral worker delivering a combined cellular and gene therapy to attenuate lung fibrosis.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Royal Institution of Great Britain</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ESPRC Nano-technology Grand Challenge</gtr:description><gtr:id>DC99C228-B81F-4950-985D-E9B4AF053664</gtr:id><gtr:impact>EPSRC Nanotechnology grand challenge grant 2009-2012. PMID: 19920196</gtr:impact><gtr:outcomeId>493E1B910EE-1</gtr:outcomeId><gtr:partnerContribution>Quentin Pankhurst (the cheif investigator) supplies nanoparticles and the MACH heating system enabling me to deliver a cellular therapy carrying nano-particle that can trate cancers through hyperthermia. Mark Lythgoe a co-applicant performs MRI imaging of these lesions.</gtr:partnerContribution><gtr:piContribution>I have a post doctoral fellow setting up cancer models and delivering MSCs carrying the nano-particle therapeutics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Scotland Royal College of Physicians</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A7DD7243-720F-4499-9053-3CC8F9677410</gtr:id><gtr:impact>State of the Art lecture

Delivered the findings of my research to general physicians in Scotland</gtr:impact><gtr:outcomeId>BD3927CFAC1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Show</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>E7FA7C8F-6DD4-49B4-B3CA-B517C386C14E</gtr:id><gtr:impact>Case Notes Radio Four Show on lung Cancer, BBC radio five live, BBC world service

I delivered my research finding to a wide audience.</gtr:impact><gtr:outcomeId>7B14ABB1845</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Conference</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>51F84EBD-F3F2-4FD5-8DC7-3E108401D9CB</gtr:id><gtr:impact>I gave a press conference after the publication of my paper describing the use of MSCs for meatastatic lung cancer. This generated articles in the Times, Telegraph, Mirror and Daily Mail. I appeared on BBC radio Five and the World Service. I appeared on the BBC TV London News, discussing the work.

The above led to a wide population seeing the work and a large response from the general public interested in the work.</gtr:impact><gtr:outcomeId>64EFD422D56</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal College lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DB5704F5-80AC-4CCB-B75C-9D424E6D7256</gtr:id><gtr:impact>State of the Art Royal college lecture

Delivered the findings of my research to a general physician audience.</gtr:impact><gtr:outcomeId>38549A3E213</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship G0900380</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>64F55A3F-C799-4666-A2B5-2287A1CABF8E</gtr:id><gtr:outcomeId>f51Z3V73wqo0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CTAAC Clinical Trial Grant</gtr:description><gtr:end>2022-10-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>B6B2097E-FB86-4D34-8821-1C6BF559F6CA</gtr:id><gtr:outcomeId>58c7d60c41fff3.68718975</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship G0800465</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7CF63609-1666-4F1A-8B42-8CC393EC6157</gtr:id><gtr:outcomeId>6F6A47E97FA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>280000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Training Fellowship</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F3FC3FA6-C4F8-42C9-9158-9F645B6D28B0</gtr:id><gtr:outcomeId>58c7d8764d55d9.61985337</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E6EC501E-DAE9-4C5E-A4EC-318115934613</gtr:id><gtr:outcomeId>Htoj8kNZk360</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Newton International Fellowship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Royal Society and Department for International Development Network Grant</gtr:fundingOrg><gtr:id>57E825BC-6C77-4A72-BF76-280B158F2F14</gtr:id><gtr:outcomeId>58c7d5b70939a6.77991527</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146955</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Roy Castle Lung Cancer Foundation</gtr:fundingOrg><gtr:id>0B24856B-5D48-4F06-9D4C-F882EF6CFFF1</gtr:id><gtr:outcomeId>58c7d7f2c8eb82.11859619</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1658140</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Senior Fellowship in Clinical Sciences (Mesenchymal Stromal Cells as Therapeutic Vectors for Metastatic Cancer)</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>AAF03945-DAB3-4EAB-A699-EF060BD5A9BC</gtr:id><gtr:outcomeId>N72FEtgcUNu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Research Society Fellowship</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>39F4217E-EA17-4A05-9085-46E873171927</gtr:id><gtr:outcomeId>A07CAD87F440</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>149599</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Roy Castle Lung Cancer Foundation</gtr:fundingOrg><gtr:id>41A9C334-5F19-48E1-8481-0A769212E6B8</gtr:id><gtr:outcomeId>58c7d4c27c77c2.25205033</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>74603</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Roy Castle Lung Cancer Foundation</gtr:fundingOrg><gtr:id>593AA2C6-0438-4001-8937-FADE03910060</gtr:id><gtr:outcomeId>58c7d831d58a25.46567052</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>492000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Biomedical Resarch Centre Funding, Strategic Grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>033F53AA-FBEF-4A5C-B0FF-EF56C49FBF17</gtr:id><gtr:outcomeId>D6568C5D0E50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERS, Long Term Training Fellowship</gtr:description><gtr:end>2009-07-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>CF48DB08-2CFE-4B17-9ABA-FFBAD7DC7E99</gtr:id><gtr:outcomeId>637C8D7D7FA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0F3F4F11-1D93-476D-84E5-4E8712135318</gtr:id><gtr:outcomeId>dPf9Mph5yNA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Johnson and Johnson Focussed Giving</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>F19CBAF6-724A-4CB5-81EB-30804C32C1D9</gtr:id><gtr:outcomeId>8B9F5FB2D1A0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>101000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BLF Project Grant</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>27C2ACEA-7F6E-4791-B85D-F95BF1A7A39C</gtr:id><gtr:outcomeId>8BE817E91D40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The use of combined mesenchymal stem cells and nanoparticles in the treatment of cancer</gtr:description><gtr:grantRef>G108/596</gtr:grantRef><gtr:id>220C24EA-7358-46C3-8CFC-8C89943D145D</gtr:id><gtr:impact>Further funding from Johnson and Johnson has been obtained</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>hqhK3K5xS8j</gtr:outcomeId><gtr:patentId>US20120010499</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Use of Nanoparticles for Cancer Treatment</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health policy on Mesothelioma Research</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>820D5F26-4874-42B6-A615-E861F1B24EF1</gtr:id><gtr:impact>Directing future research funding</gtr:impact><gtr:outcomeId>bdH7zRPJmw6</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>I sit on the national committee for invasive bronchoscopy.</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>88228A4C-0AFE-4D91-AC6D-02088BB1C2AC</gtr:id><gtr:impact>nil yet</gtr:impact><gtr:outcomeId>3C7C509C937</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Thoracic Oncology Group</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>C8093520-788E-46CE-836D-834BB1733586</gtr:id><gtr:impact>Directing National Meetings and advising on health documents</gtr:impact><gtr:outcomeId>DhR6KYdBMuG</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Cohort of biopsy material from rare pre-invasive lung tissue</gtr:description><gtr:id>9E24B3F6-659D-421F-A8E3-86C6003E5DF3</gtr:id><gtr:impact>Contribution towards a pre-invasise gene atlas</gtr:impact><gtr:outcomeId>F68467DB5F6</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human Lung Biopsies</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BDA049DC-A327-4AC3-BEAD-8719371D072A</gtr:id><gtr:title>Therapeutic potential of stem cells in lung disease: progress and pitfalls.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>8573347063F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4FB660E-BE88-43BE-9CAD-216F4EA286A1</gtr:id><gtr:title>Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41b3a8ac875fd5626116668ac4604170"><gtr:id>41b3a8ac875fd5626116668ac4604170</gtr:id><gtr:otherNames>Vallath S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58c7d790421ab8.07663872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F3E41A4-8450-4C98-9B4D-268A9EB2039E</gtr:id><gtr:title>Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d2308eaa4af4e3fb62e1b227ef285af"><gtr:id>6d2308eaa4af4e3fb62e1b227ef285af</gtr:id><gtr:otherNames>Hynds RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>5a9e8ae81d92a3.53294014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0B82951-D439-4100-B87D-FB40603A290D</gtr:id><gtr:title>The role of bone marrow-derived stem cells in lung regeneration and repair</gtr:title><gtr:parentPublicationTitle>StemBook</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93d354d48d7e019fa9e84511bbd51bee"><gtr:id>93d354d48d7e019fa9e84511bbd51bee</gtr:id><gtr:otherNames>Sage Elizabeth K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>LhUUNAJWQzu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AF2E226-9C8C-4794-BEFD-6F334CCE5406</gtr:id><gtr:title>Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>C1A55C9CF30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63436762-A0F0-4868-94BF-09C6695E956B</gtr:id><gtr:title>Preinvasive disease of the airway.</gtr:title><gtr:parentPublicationTitle>Cancer treatment reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a8cb496693fadbdb1ff6475b00af8d9"><gtr:id>6a8cb496693fadbdb1ff6475b00af8d9</gtr:id><gtr:otherNames>Thakrar RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-7372</gtr:issn><gtr:outcomeId>5a9e8ae9e855c5.04936801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DCA74E6-34B4-46BC-A63F-FE352AA4432C</gtr:id><gtr:title>Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>7D4408ACFF4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>298E82A1-A6EB-425A-8D07-3112D6F3C1F6</gtr:id><gtr:title>Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4554e2051f9b323489c56abb888aea6a"><gtr:id>4554e2051f9b323489c56abb888aea6a</gtr:id><gtr:otherNames>Abbosh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a9e8ae9c0c852.84304552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8757074-9862-4A4A-8D02-4AE3B0DF51C9</gtr:id><gtr:title>Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn><gtr:outcomeId>6BA7F19D359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00FF3FA9-E308-4D1C-9E10-95F33C6D4F1D</gtr:id><gtr:title>Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>737F1B63EB7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6422FEE-EC73-4B94-ADB2-7A86B670FC47</gtr:id><gtr:title>?-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723d2b0b4df44ee7eeea5fff71a44b86"><gtr:id>723d2b0b4df44ee7eeea5fff71a44b86</gtr:id><gtr:otherNames>Giangreco A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>edq7ffpzhdb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>625B8CBD-22D3-4A78-ACB0-92F826024F29</gtr:id><gtr:title>Airway Basal Cell Heterogeneity and Lung Squamous Cell Carcinoma.</gtr:title><gtr:parentPublicationTitle>Cancer prevention research (Philadelphia, Pa.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d2308eaa4af4e3fb62e1b227ef285af"><gtr:id>6d2308eaa4af4e3fb62e1b227ef285af</gtr:id><gtr:otherNames>Hynds RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1940-6215</gtr:issn><gtr:outcomeId>5a9e8ae972c956.28678515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E865A2D-DC75-4AD6-B75D-6793421D122F</gtr:id><gtr:title>Lung cancer and lung stem cells: strange bedfellows?</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723d2b0b4df44ee7eeea5fff71a44b86"><gtr:id>723d2b0b4df44ee7eeea5fff71a44b86</gtr:id><gtr:otherNames>Giangreco A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>2E40DB1E319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9D2CCC8-CE45-49B9-AED5-367270D64C2E</gtr:id><gtr:title>Stem cells for lung disease.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>04461FCB5D8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14713048-5448-4F12-81B2-F30E014FAAB8</gtr:id><gtr:title>A rare asthma mimic exposed by basic physiology.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>o8JCYgquua1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5D96074-14BE-4C5E-9821-1BEB11C2C9A6</gtr:id><gtr:title>Stem cells as vectors for antitumour therapy.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>WvMdjnH9eE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B01EC44B-69A4-4280-A0FD-3AD75B2AD621</gtr:id><gtr:title>PI3-kinase-dependent activation of apoptotic machinery occurs on commitment of epidermal keratinocytes to terminal differentiation.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cbd4704e8b558ff7905c34d182c507c"><gtr:id>9cbd4704e8b558ff7905c34d182c507c</gtr:id><gtr:otherNames>Janes SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>B886C9BFB48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0010113E-DCFC-4B48-AC4B-E1C494A0935E</gtr:id><gtr:title>New roles for integrins in squamous-cell carcinoma.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cbd4704e8b558ff7905c34d182c507c"><gtr:id>9cbd4704e8b558ff7905c34d182c507c</gtr:id><gtr:otherNames>Janes SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-175X</gtr:issn><gtr:outcomeId>65B239D23AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2766645-9A54-4470-96ED-D61715604F6B</gtr:id><gtr:title>Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91b875c1680837c322d2fa0d7b76db63"><gtr:id>91b875c1680837c322d2fa0d7b76db63</gtr:id><gtr:otherNames>Aguilar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>24608ECF58A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97938111-91F4-4F0C-9B0B-C3A53EB79BE5</gtr:id><gtr:title>Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4554e2051f9b323489c56abb888aea6a"><gtr:id>4554e2051f9b323489c56abb888aea6a</gtr:id><gtr:otherNames>Abbosh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a9e8ae7c91915.46110581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5D5C772-7683-4803-A1B4-62AC678430CC</gtr:id><gtr:title>Optimized isolation and expansion of human airway epithelial basal cells from endobronchial biopsy samples.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f39e7f67c15e7fa63377e45e027fc19a"><gtr:id>f39e7f67c15e7fa63377e45e027fc19a</gtr:id><gtr:otherNames>Gowers KHC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>5a9e8aea2b64c5.66304152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32CF23F3-3B96-429A-A3D6-59DFE6B547C3</gtr:id><gtr:title>TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>tLFkXqzN83u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E9F1DFC-A968-472A-BC22-1F3FBA9AE7F7</gtr:id><gtr:title>Mesenchymal stem cells as vectors for lung disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>86153AC0E09</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8C27E21-5DD5-4550-BD0A-F9968197B602</gtr:id><gtr:title>Catheter-tract metastases associated with chronic indwelling pleural catheters.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cbd4704e8b558ff7905c34d182c507c"><gtr:id>9cbd4704e8b558ff7905c34d182c507c</gtr:id><gtr:otherNames>Janes SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>D6650A57042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F889E65-3574-413C-8292-F31DC7FE4A5B</gtr:id><gtr:title>Tracking the Evolution of Non-Small-Cell Lung Cancer.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3324dd043ac960b370ef51b0cf7efb0b"><gtr:id>3324dd043ac960b370ef51b0cf7efb0b</gtr:id><gtr:otherNames>Jamal-Hanjani M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5a9e8ae92de799.28950278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F863283D-223E-4D7D-A1BC-079FDB7F7482</gtr:id><gtr:title>Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91b875c1680837c322d2fa0d7b76db63"><gtr:id>91b875c1680837c322d2fa0d7b76db63</gtr:id><gtr:otherNames>Aguilar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>769106D0E34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04F82D89-4CFB-440D-94A9-824EA9C27CD7</gtr:id><gtr:title>Rac1 deletion causes thymic atrophy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6beb09308490bb95e55f5a105ebb467"><gtr:id>d6beb09308490bb95e55f5a105ebb467</gtr:id><gtr:otherNames>Hunziker L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c7d78b2ff272.19569054</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/596</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>